STANFORD UNIVERSITY

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1885-11-11

Employees: 10K

Market Cap: -

Website: http://www.stanford.edu

Clinical Trials

Compassion Training and Pain

Not Applicable

Completed

Conditions: Chronic Pain

Interventions: Behavioral: Compassion Cultivation Training Course

First Posted Date: 2013-01-28

Last Posted Date: 2013-12-16

Lead Sponsor: Stanford University

Target Recruit Count: 56

Registration Number: NCT01776645

Locations: 🇺🇸
Stanford University School of Medicine, Palo Alto, California, United States

A Sleep-Oriented Intervention for Suicidal Behaviors

Not Applicable

Completed

Conditions: Insomnia
Suicidal Ideation

Interventions: Behavioral: Behavioral Insomnia Treatment

First Posted Date: 2013-01-18

Last Posted Date: 2020-03-02

Lead Sponsor: Stanford University

Target Recruit Count: 37

Registration Number: NCT01770587

Locations: 🇺🇸
Stanford University, Dept. of Psychiatry and Behavioral Sciences, Stanford, California, United States

Pilot Indocyanine Green Imaging for Mapping of Arm Draining Lymphatics & Nodes in Breast Cancer

Phase 2

Completed

Conditions: Breast Cancer

Interventions: Device: SPY Elite Imaging
Drug: Indocyanine Green
Drug: Isosulfan blue
Drug: 99technetium-sulfur colloid radiolabel

First Posted Date: 2013-01-18

Last Posted Date: 2017-12-11

Lead Sponsor: Stanford University

Target Recruit Count: 23

Registration Number: NCT01771666

Locations: 🇺🇸
Stanford University, School of Medicine, Stanford, California, United States

Ipilimumab and Local Radiation for Selected Solid Tumors

Phase 1

Terminated

Conditions: Intraocular Lymphoma
T-cell Large Granular Lymphocyte Leukemia
Adult Nasal Type Extranodal NK/T-cell Lymphoma
Anaplastic Large Cell Lymphoma
Angioimmunoblastic T-cell Lymphoma
Hepatosplenic T-cell Lymphoma
Peripheral T-cell Lymphoma
Recurrent Adult Burkitt Lymphoma
Recurrent Adult Diffuse Mixed Cell Lymphoma
Recurrent Adult Diffuse Small Cleaved Cell Lymphoma

Interventions: Biological: Ipilimumab
Radiation: Radiation therapy

First Posted Date: 2013-01-16

Last Posted Date: 2024-01-24

Lead Sponsor: Stanford University

Target Recruit Count: 3

Registration Number: NCT01769222

Locations: 🇺🇸
Stanford University, Stanford, California, United States

Bortezomib and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia

Phase 2

Completed

Conditions: Recurrent Adult Acute Lymphoblastic Leukemia (ALL)
Ph-positive Adult Acute Lymphoblastic Leukemia (ALL)
B-cell Adult Acute Lymphoblastic Leukemia (ALL)
T-cell Adult Acute Lymphoblastic Leukemia (ALL)

Interventions: Drug: Bortezomib
Drug: Doxorubicin hydrochloride (HCl)
Drug: PEG-Asparaginase
Drug: Vincristine sulfate
Drug: Dexamethasone
Drug: Cytarabine
Drug: Methotrexate

First Posted Date: 2013-01-16

Last Posted Date: 2018-11-14

Lead Sponsor: Stanford University

Target Recruit Count: 18

Registration Number: NCT01769209

Locations: 🇺🇸
Stanford University, School of Medicine, Stanford, California, United States

Perioperative Aminophylline to Improve Early Kidney Function After a Kidney Transplant

Not Applicable

Completed

Conditions: Function of Renal Transplant

Interventions: Drug: Aminophylline
Other: Theophylline drug levels
Drug: Placebo

First Posted Date: 2013-01-03

Last Posted Date: 2019-03-05

Lead Sponsor: Stanford University

Target Recruit Count: 50

Registration Number: NCT01759862

Locations: 🇺🇸
Lucile Packard Children's Hospital at Stanford, Stanford, California, United States

Evaluation of a Non-invasive Brain Compliance Measurement Device

Completed

Conditions: Diabetes
Diabetic Ketoacidosis

Interventions: Other: this is not an intervention study
Device: MRI

First Posted Date: 2012-12-20

Last Posted Date: 2019-11-13

Lead Sponsor: Stanford University

Target Recruit Count: 14

Registration Number: NCT01753921

Locations: 🇺🇸
Stanford University, Stanford, California, United States

Diabetic Ketoacidosis and Its Impact on the Brain

Completed

Conditions: Diabetes Mellitus

First Posted Date: 2012-12-20

Last Posted Date: 2019-11-13

Lead Sponsor: Stanford University

Target Recruit Count: 24

Registration Number: NCT01753934

Locations: 🇺🇸
Stanford University School of Medicine, Stanford, California, United States

Inflammatory Responses to Acute and Chronic Opioid Exposure in Humans

Not Applicable

Terminated

Conditions: Inflammation

Interventions: Drug: Morphine Sulfate

First Posted Date: 2012-12-17

Last Posted Date: 2019-01-30

Lead Sponsor: Stanford University

Target Recruit Count: 20

Registration Number: NCT01749826

Locations: 🇺🇸
Stanford University School of Medicine, Stanford, California, United States

Specific Carbohydrate Diet as Maintenance Therapy in Crohn's Disease

Completed

Conditions: Crohn's Disease

First Posted Date: 2012-12-17

Last Posted Date: 2018-02-08

Lead Sponsor: Stanford University

Target Recruit Count: 8

Registration Number: NCT01749813

Locations: 🇺🇸
Stanford University Medical Center, Palo Alto, California, United States
🇺🇸
Stanford, Palo Alto, California, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy